The three genes located to 7q21.3 would be candidates for myeloid tumor-suppressor genes on 7q.
Introduction
Monosomy 7 and interstitial deletions in 7q (-7/7q-) are a common nonrandom chromosomal abnormality found frequently in myeloid disorders. In 1964, prior to chromosome band identification, monosomy 7 was first reported in three patients with refractory anemia as monosomy of a C-group chromosome [1] . Since that time, -7/7q-have been identified in 10-20% of a wide range of myeloid malignancies including MDS, AML and JMML [2] .
Enormous efforts have been made to identify genes responsible for -7/7q-.
In the absence of definitive familial cases, the basic strategy for gene hunting began with identifying patients that carried 7q-. Detailed maps of regions deleted from individual patients were then generated from the results of loss of heterogeneity assays or fluorescence in situ hybridization. Unfortunately, the cumulative results from thousands of patients were confounded by the fact that the boundaries of commonly deleted regions derived by separate research groups showed a poor degree of overlap [3] .
Currently, it is generally accepted that two or more genes near bands 7q22 and/or 7q34 are involved in myeloid tumors.
Microarray-based comparative genomic hybridization (mCGH) technology allows efficient detection of microdeletions (<100 Kb) that affect one or a few genes, enabling to search for small 7q deletions that are not visible cytogenetically in marrow cells of MDS/AML patients. Initially, bacterial artificial chromosome (BAC)-based mCGH systems were developed, but this system had limited potential to detect microdeletions because of the long probe size (>100 Kb). Thereafter, SNP-array hybridization turned out to be a powerful method for detecting not only single nucleotide polymorphism, but also microdeletions [4] . However, because SNPs tend to cluster within introns and intergenic spaces, SNP-array hybridizations may bias against the detection of microdeletions in critical genes.
Here we describe the application of a modified BAC-based mCGH system that uses short (<10 Kb) genomic DNA fragments without any repetitive sequences as probes to improve the detection of small deletions and reduce background hybridization.
Because repeat-free fragments generally overlap exon-containing regions, this type of probe not only yields a high signal/noise ratio, but also can be useful in determining the copy number of a corresponding gene. Using this system for identification of 4 responsible gene(s) for -7/7q-, we report the isolation of a common microdeletion among JMML patients that contains three poorly characterized genes.
Materials and methods
Short probe-based mCGH. This system was similar to that described by others [5] .
Briefly, total 292 repeat-free segments (2.7-9.5 Kb) were identified using BlastN at the NCBI server (235 probes in 7q21.2-7q31.1, 15 in 4q12, 27 in 20q, and 15 in 21q).
Each of these fragments was PCR amplified from human placenta DNA (Clontech, Mountain View, CA) and cloned into the pCR-XL-TOPO vector (Invitrogen, Carlsbad, CA). The primer sets used to amplify probes #14 to #16 are listed in Table 1 . Sequences of other primer sets are available upon request. Five micrograms of each target DNA, amplified by PCR from each cloned fragment using universal primers in the vector, were printed on poly-L-lysine coated glass slides (Matsunami Glass, Osaka, Japan) using a spotter (SPBIO, Hitachi Software, Tokyo, Japan). Bone marrow samples were obtained after informed consent and approval from the institutional review board at Hiroshima University. Test samples and reference placenta DNA (2.5 μg) were random-prime labeled with CY3-and CY5-dCTP (GE healthcare), respectively, and then hybridized to the slide. Scanning of microarrays was performed using G2505A scanner (Agilent Technologies, Santa Clara, CA) and signals were analyzed with ArrayVision (GE healthcare).
Cell culture and gene transfer. 293 and HeLa(tc) [6] cells were cultured in Dulbecco's modified Eagle medium supplemented with 10% fetal bovine serum (FBS). siRNA oligonucleotides (100 nM, otherwise indicated, Table 2 ) were transfected using Oligofectamine (Invitrogen). C-terminal FLAG-tagged Mikiα or β protein, or MikiΔN-FLAG(C) protein (lacking N-terminal hydrophobic 30 aa of Mikiβ) was expressed using the pcDNA3 expression vector (Invitrogen).
Other experimental procedures and reagents. Copy number assessment by qPCR was performed according to the procedure described [7] . qRT-PCR was performed as previously described [8] , but with HPRT as the internal control. Primer sets used are listed in Table 1 . Immunoprecipitation and immunoblot analyses were performed according to standard procedures [9] using 2% gelatin as a blocking agent.
Immunostaining and image analyses were performed as described [6; 10] . Rabbit anti-Miki antibody was raised against GST-Mikiα (aa. 377-462) and affinity purified according to the standard procedures [9] .
Results
Identification of three candidate myeloid tumor-suppressor genes in a common microdeletion cluster among JMML patients Two hundred thirty-five probes in a region spanning 21.7 Mb within 7q21.2-7q31.1 and additional 57 control probes in 4q, 20q, and 21q were applied to a search for microdeletions using a short probe-based mCGH system (see Materials and Methods). Test (leukemia) and reference DNA samples were labeled with CY3-and CY5-dCTP, respectively, and then hybridized to slides on which probes were printed.
We initially selected fresh bone marrow samples from adult AML/MDS patients or DNA from myeloid leukemia cell lines that did not show apparent 7q abnormalities. However, gross regional copy number changes were still detected frequently (Fig. 1A) . In addition, 'single copy events', which could include both real copy number changes in a small region and noise of the system, were frequently observed. To test whether this system can detect bona fide copy number changes in a small region, we applied this system to genomic DNA extracted from an eosinophilic leukemia cell line, EOL-1, which is known to harbor a deletion spanning 800 Kb between the Rhe (FIP1L1) gene and the PDGFα gene in 4q [11] . All eight probes (#239-#246) that locate within the deletion showed low fluorescence ratios (Fig. 1B, bracket), as well as many single copy events that were also detected in this cell line.
We then applied the microarray CGH system to samples from JMML patients, which is a subtype of MDS and is occasionally associated with monosomy 7 [2] . In contrast to adult MDS/AML patients and cell lines, JMML patients mostly carried no gross regional copy number changes nor single copy events (Fig. 1C) . However, three contiguous probes (#14-#16) in the 7q21.2-21.3 sub-band were repeatedly found to show a low fluorescence ratio (Fig. 1D ). In eight of the 21 JMML patients, at least one of these three probes detected a microdeletion in one allele (Fig. 1E , left), suggesting that a region containing these probes is deleted frequently in JMML.
Three contiguous genes (Samd9, Samd9L and LOC253012) identified by the human genome sequencing consortium (http://www.ncbi.nlm.nih.gov/) were found to overlap probes #14, #15 and #16, respectively ( Fig. 2A ). This region does not contain any known copy number polymorphisms (CNPs) [12] , nor does it represent any microRNA sequence in miRBase [13] (http://microrna.sanger.ac.uk/).
To confirm the presence of a microdeletion cluster in chromosome 7 of JMML patients, we prepared five primer sets for real-time quantitative PCR analyses (qPCR) that efficiently amplify DNA fragment to allow estimating the copy number of each of these three genes ( Fig. 2A ) [7] . One allele loss of either one of the three genes was detected in all four patients whose DNA samples were available (Fig. 1E, right) .
We then extended the qPCR copy number assessment to 65 adult patients with MDS or AML using the five primer sets for the three genes and additional sets for control genes on chromosome 7 and other chromosomes (Fig. 2B ). Nearly 30% (19/65) of patients showed loss of one allele in at least one of the three genes, indicating that these three genes are heterozygously deleted at high frequency in both adult and childhood myeloid leukemia. In contrast to the chromosome 7 microdeletions among JMML patients ( (Fig. 3B, left) , which co-localized with Golgi-markers such as Golgin-97 in the interphase (middle).
In mitosis, Miki immunostaining localized to centrosomes/spindles (right).
Miki seems to be modified post-translationally in a complex way. Four major bands were detected in immunoblots of 293-cell extracts with anti-Miki antibody (Fig. 3C, lane 1 shRNA-expressing vectors demonstrate that three shRNAs (#1, #3, #6) downregulated levels of glycosylated Miki efficiently (Fig. 4A) . When cells were transfected with the shRNA-expressing vectors alone, shRNAs expressed from piGENE-mU6(neo)-hMiki#1, #3 or #6 also downregulated steady-state levels of endogenous Miki p125 and p50 (and p100 and p60 less effectively) (Fig. 4B) .
In an alternate experiment, three Miki-based short interference RNAs (siRNAs) reduced steady-state levels of Miki mRNA to varying degrees when transfected directly into 293 cells (Fig. 4C) . Immunoblots prepared from these cells showed that the intensities of Miki p125 and p50 signals (and p100 and p60 less effectively) were attenuated within 48 hours of transfection with siRNA#79 or siRNA#80 (Fig. 4D frequently (approximately 20%) contained more than two nuclei (Fig. 4F, left) . (Fig. 4G ).
Discussion
Here we identified a microdeletion cluster among JMML patients within 120 kb in 7q21.3 subband. This cluster contains three poorly characterized genes: Miki (LOC253012), Samd9 and Samd9L. Since single gene deletion of Samd9 or Miki was proved by two independent methods (mCGH and qPCR) in patient #1 or #8, respectively, we prefer to consider that three genes, rather than one of them, are candidates for myeloid tumor-suppressors on 7q. Three genes are also deleted in adult MDS and AML either as a part of large deletions or single gene loss (Fig. 2C) .
Among systems detecting microdeletions, SNP-array hybridization becomes the first choice for primary screening [4] . However, because SNPs tend to cluster within introns and intergenic spaces, SNP-array may not always be the best. For instance, although there are 9 SNP probes in this microdeletion cluster in Genome-Wide SNP6.0 system (Affymetrix), no probes can detect Samd9 gene deletion ( Fig. 2A,   bottom ). In addition, only one probe (A-866741) locates to coding region, casting doubt on the potential of SNP-array to detect small deletions in the critical genes.
Application of the short probe-based mCGH to samples containing few copy number abnormalities (such as JMML) would be a good alternative of SNP-array.
In myeloid tumors, -7/7q-has been most implicated in pathogenesis of MDS, which is characterized by myelodysplasia (morphological abnormality in hematopoietic progenitors) [2] . Myelodysplasia includes abnormal nuclear morphologies, such as bi-, Recently, point mutations of Samd9 was reported as a causative gene alterations in Normophosphatemic Familial Tumoral Calcinosis, a rare autosomal recessive disorder in five families of Jewish-Yemenite origin [14; 15] . In addition, downregulation of Samd9 was reported to be implicated in aggressive fibromatosis [16] , suggesting that Samd9 could be a tumor suppressor. However, Samd9/Samd9L do not show significant homology to any other genes and no biological functions were elucidated.
We overexpressed or downregulated Samd9 or Samd9L in various human cells and found no prominent phenotypes, possibly because functional redundancy of these two proteins.
Because there is only Samd9L gene in mouse genome [16] , Samd9L-deficient mice would show unambiguous phenotypes. Indeed, currently we are accumulating phenotypes from Samd9L-deficient mice that support our hypothesis that Samd9/Samd9L are myeloid tumor-suppressors. 
